The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: A randomized, double-blind, placebo-controlled trial

Journal of Infectious Diseases

Volumn 176, Issue 6, 1997, Pages 1517-1523

  Deeks, S G ^a   Collier, A ^a   Lalezari, J ^a   Pavia, A ^a   Rodrigue, D ^a   Drew, W L ^a   Toole, J ^a   Jaffe, H S ^a   Mulato, A S ^a   Lamy, P D ^a   Li, W ^a   Cherrington, J M ^a   Hellmann, N ^a   Kahn, J ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030722272     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514150     Document Type: Article

References (34)